Windjammer Capital acquires monoclonal antibodies producer Bio X Cell

Windjammer Capital Investors ("Windjammer"), a notable private equity investment firm, has announced its acquisition of Bio X Cell, LLC ("BXC"), marking a significant move in ... Read More